Abstract
Background and Aim The process of flame-cutting and welding is believed to highly hazardous for workers involved in related industries. The study aims to provide a comprehensive quantitative effect of the risk of lung cancer due to exposure to welding fumes.
Methods A systematic review was conducted to extract published estimates of odd’s ratio of the association of lung cancer and exposure to welding fumes, till 2022. Studies were extracted from the PubMed database with clearly defined inclusion and exclusion criteria. Studies from all parts of the world were considered. A meta-analysis with random effects model was conducted resulting in formation of forest plot, influence analysis, sensitivity analysis and checking for publication bias using a funnel plot.
Results The meta-analysis yielded an OR of 1.256 (95% CI 1.055-1.496), with a moderately high heterogeneity between the studies (I2 = 68.78% ; τ2 = 0.039; Q = 36.115(p < 0.001)). The sensitivity and influence analysis confirmed the absence of highly influential studies that may have led to potentially distorted outcomes. The funnel plot showed no evidence of publication bias among the studies included in this analysis.
Conclusion As the association of lung cancer and occupational hazards from exposure to welding fumes is certain, there is a need to control and regulate industrial activities that involve welding and flame cutting. Already, restrictions on safe levels of fume in workplace is in operation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.